Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the ...

Researchers note that toxin appeared to concentrate its effects within tumour tissue and did not cause any harmful ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Cholera toxin shows promise against colon cancer by targeting tumors precisely while sparing healthy tissue, unlike brutal ...

Philip Felshman was given only a few years to live. The otherwise healthy New Yorker described the news as a "big shock." He'd been happily working for 33 years as a service manager, enjoying time ...